【摘要】 目的探讨人参皂苷Rd在大鼠体内的代谢产物及转化途径。方法选择SD大鼠6只,单剂量口服和静脉给予人参皂苷Rd,分段收集给药前和给药后0~24 h尿样,将尿样分时段合并后采用旋转薄膜蒸发浓缩,以固相萃取小柱纯化处理,采用高效液相色谱-串联飞行时间质谱进行检测。结果通过比较给药前后的TOF总离子流图,对尿中推测的代谢物和标准物质的出峰时间及相关化合物选择离子扫描二级质谱图进行了比较分析,结果在尿中发现了7种代谢产物,系统分析了这些代谢产物的代谢转化规律及可能结构。结论大鼠尿中人参皂苷Rd的主要转化途径为氧化、水解、结合及异构化代谢反应。更多还原

【Abstract】 Aim To study the metabolic pathways of ginsenoside Rd in rats.Methods Urine samples were collected before and after 24 h of single oral administration of 150 mg and intravenous administration of 60 mg of ginsenoside Rd to six rats,separately.The samples were purified by SPE column and then were analyzed by liquid chromatography-ESI-mass spectrometry for putative metabolites.Results Parent drug and its seven metabolites were identified in rat urine based on comparing total ion chromatograms of the blank with the metalolic urine as well as mass spectra.Its main metabolic pathways and possible structures are elucidated.Conclusion Oxidation,combination and deglucosylation were found to be the major metabolic pathway of ginsenoside Rd in rats.更多还原